Ozempic and Mounjaro makers point to unexpected anti-aging effects
New data from pharmaceutical giants Novo Nordisk and Eli Lilly suggests that GLP-1 medications could slow down molecular aging clocks by several years.
Latest stories, in-depth analysis & breaking updates
New data from pharmaceutical giants Novo Nordisk and Eli Lilly suggests that GLP-1 medications could slow down molecular aging clocks by several years.